Preparing for Hybrid Effectiveness-Implementation Trials for Heart, Lung, Blood, and Sleep Diseases in the Inpatient Setting (U01 Research Project—Cooperative Agreement)

Aug 11,2017 | Consortium_staff Funding Opportunities

Posted by: NIH (RFA-HL-18-018)
Post date: July 14, 2017
Letter of Intent (LOI) due date: September 30, 2017
Due date: October 31, 2017

The purpose of this Funding Opportunity Announcement (FOA) is to support investigators performing research to identify the barriers and facilitators to implementation of an evidence-based practice(s) for heart, lung, blood, and sleep (HLBS) diseases in the inpatient setting. NHLBI is seeking applications that will utilize an implementation research framework to develop an implementation strategy (or strategies) to be tested during a subsequent hybrid effectiveness-implementation trial. During this grant, investigators will measure the “baseline” or “usual care” practice with respect to the evidence-based practice(s) of interest and plan for the subsequent trial. This FOA intends to support applications that propose a multidisciplinary research team that includes both inpatient clinical research expertise and implementation research expertise. At the conclusion of this U01, awardees and other qualified applicants may be ready to apply to a separate NHLBI-funded FOA, described in NOT-HL-17-493, to support the trial.

Read RFA-HL-18-018 for more information.